CBD Life Sciences (CBDL)
OTHER OTC:CBDL
US Market

CBD Life Sciences (CBDL) Financial Statements

128 Followers

CBD Life Sciences Financial Overview

CBD Life Sciences's market cap is currently ―. The company's EPS TTM is $0; its P/E ratio is ―; CBD Life Sciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 15Jun 15Mar 15Dec 14Sep 14
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 122.79K$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 122.79K$ 0.00
EBIT$ -21.72K$ -29.78K$ -20.30K$ -27.74K$ -436.23K
EBITDA$ -18.45K$ -26.07K$ -16.09K$ -22.97K$ -430.81K
Net Income Common Stockholders$ -21.72K$ -29.78K$ -20.30K$ -31.32K$ -439.61K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Total Assets$ 620.89K$ 624.16K$ 627.87K$ 632.08K$ 678.18K
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Total Liabilities$ 411.60K$ 393.15K$ 367.08K$ 645.45K$ 844.48K
Stockholders Equity$ 209.29K$ 231.01K$ 260.79K$ -13.37K$ -166.30K
Cash Flow-
Free Cash Flow---$ -125.35K$ -295.42K
Operating Cash Flow---$ -125.35K$ -295.42K
Investing Cash Flow---$ 0.00$ 0.00
Financing Cash Flow---$ 125.35K$ 295.42K
Currency in USD

CBD Life Sciences Earnings and Revenue History

CBD Life Sciences Debt to Assets

CBD Life Sciences Cash Flow

CBD Life Sciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis